搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 天
AAD awarded BARDA contract to develop next gen CBC, sepsis diagnostic system
Ad Astra Diagnostics (AAD), developer of rapid diagnostic and data systems, today announced that it has been awarded a ...
1 天
Edmonton MedTech Start-Up MACH32 Awarded Research and Development Contract From BARDA To ...
MACH32 announced today that it has been awarded an EZ-BAA Advanced Research and Development contract from Biomedical Advanced ...
BioWorld
3 天
Grifols partners with BARDA to test ocular immunoglobulin for sulfur mustard-induced eye damage
Grifols SA has entered into a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to ...
3 天
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as ...
Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from ...
3 天
Grifols partners with BARDA for PoC testing of ocular immunoglobulin
Grifols (GRFS) has established a partnership with the Biomedical Advanced Research and Development Authority to test investigational ocular ...
360dx
1 天
Ad Astra Diagnostics Receives $5M BARDA Contract to Develop Point-of-Care CBC System
The firm's QScout CBC diagnostic system is intended to deliver faster complete blood count test results and detect severe infection earlier.
pharmaphorum
2 天
BARDA backs Locus phage therapy for resistant E coli
The payment is part of an $85 million award from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development of LBP-EC01, which has already shown promise in ...
FiercePharma
17 小时
Sanofi shrugs off potential RSV competition from Merck as Beyfortus grows sales 382%
On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...
1 天
New $8M grant brings WFIRM's funding for miniaturized organs to over $138M
With an initial funding of $18 million, the eight-year grant will allow WFIRM to study treatments for scar-causing injuries ...
3 天
盖立复与BARDA合作开发芥子气眼部损伤治疗药物
巴塞罗那 - 全球医疗保健公司盖立复(MCE:GRF, MCE:GRF.P, NASDAQ:GRFS)宣布与生物医学高级研究和开发局(BARDA)合作,评估一种用于治疗芥子气导致眼部损伤的实验性眼药水。此次合作旨在探索目前正在开发用于干眼症(DED)的眼表免疫球蛋白(OSIG)眼药水,在中和这种化学战剂影响方面的潜力。 芥子气(俗称芥子气)会导致严重的眼部损伤,可能导致失明。临床前研究将重点关注O ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈